glp-1 conference pills, immunology, and China, oh my: JPM 2026 Obesity Medicine 2025 - Conference

While the potential cost of authorizing Medicare coverage of anti-obesity drugs has presented a barrier to enacting legislation to lift the prohibition, covering these drugs under Medicare for authorized uses has already catapulted these drugs to rank among the top-selling drugs covered by Part D, Medicares outpatient drug benefit program

STEP 2, 3, and 4 confirmed and extended the findings

These medications help manage blood sugar levels and promote feelings of fullness to support weight loss

A lot of the weight loss came from lean body mass

Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)

Ready to start your GLP-1 journey